Molusafe 200mg Capsule

Molusafe 200mg Capsule belongs to a class of drugs called antiviral agents indicated for the mild to the moderate treatment of Covid-19. Coronavirus disease/Covid-19, also known as SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2), is an infectious disease caused by the coronavirus. Its symptoms include fever and cough and, in some cases, progressing to pneumonia and respiratory failure. 

Molusafe 200mg Capsule contains Molnupiravir, a protease inhibitor. It works by interfering with a protein known as protease, which is necessary for the virus-infected cells to generate new viruses. As a result, the resulting virus particles have faulty genetic material and can no longer reproduce. Thereby, Molusafe 200mg Capsule lowers virus load in the body and helps treat the infection.

Take Molusafe 200mg Capsule as prescribed. To treat your condition effectively, you are advised to take Molusafe 200mg Capsule for as long as your doctor has prescribed it. In some cases, Molusafe 200mg Capsule may cause nausea, vomiting, diarrhoea, headache, and dizziness. Most of these side effects do not require medical attention and resolve gradually over time. However, if the side effects persist or worsen, please consult a doctor. 

Women of child-bearing potential must use effective contraception during the treatment and for 4days after the last dose. Please seek medical advice from the doctor before taking Molusafe 200mg Capsule if you are pregnant. Breastfeeding should be discontinued during the treatment and for 4days after the last dose. Molusafe 200mg Capsule may cause dizziness, so drive with caution. It is unknown whether consuming alcohol with Molusafe 200mg Capsule is safe. However, it is best to avoid alcohol consumption as it may cause increased dizziness. Keep your healthcare professional updated on your medical condition and medications to rule out any interactions.

Molusafe 200mg Capsule is an experimental antiviral medication that lowers the risk of hospitalisation or death in patients with mild or moderate covid-19. Molusafe 200mg Capsule is a potent protease inhibitor that interferes with a protein (protease) required by virus-infected cells to generate new viruses. As a result, Molusafe 200mg Capsule helps reduce viral load in the body and aids in infection therapy.

Please do not take Molusafe 200mg Capsule if you are allergic to any of its ingredients. Women of child-bearing potential must use effective contraception during the treatment and for 4days after the last dose. Please seek medical advice from the doctor before taking Molusafe 200mg Capsule if you are pregnant. Breastfeeding should be discontinued during the treatment and for 4days after the last dose. Molusafe 200mg Capsule may cause dizziness, so drive with caution. It is unknown whether consuming alcohol with Molusafe 200mg Capsule is safe. However, it is best to avoid alcohol consumption as it may cause increased dizziness. Keep your doctor updated on your medical condition and medications to rule out any interactions.

• Do not use any antipyretic or anti-allergic medication without first consulting a doctor if you develop a fever or rash after taking Molusafe 200mg Capsule.
• While taking Molusafe 200mg Capsule, specific tests may be recommended to monitor changes in blood lipids.
• Seek medical help immediately if you have a severe cough, fever, or breathing difficultly.
• Regularly monitor SpO2 (oxygen saturation levels), and report to a hospital if the levels are below 92%.